Adaptive Biotechnologies Corporation (ADPT)

Business: Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

IPO Date: 27-Jun-2019

Co-Founder, CEO & Chairman: Mr. Chad M. Robins M.B.A, M.B.A.

Pres: Ms. Julie Rubinstein

Listing: NASDAQ: ADPT

Country: United States

Headquarters: Seattle, WA

Website: https://www.adaptivebiotech.com

Market cap: $1,197.56 Mln

Revenue (TTM): $154.52 Mln

Earnings (TTM): $-229.37 Mln

Cash: $363.56 Mln

Total Debt: $113.52 Mln

Insider's Holding: 1.67%

Liquidity: Low

52 Week range: $5.96 - 40.00

Shares outstanding: 142,228,000

5 Years Aggregate:

• CFO: $-204.12 Mln
• EBITDA: $-469.38 Mln
• Net Profit: $-511.39 Mln